HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

David Sweeny Selected Research

Semaxinib (SU5416)

3/2006Distribution, metabolism, and excretion of the anti-angiogenic compound SU5416.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


David Sweeny Research Topics

Disease

2Neoplasms (Cancer)
01/2010 - 03/2006
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2010
1Leukemia
01/2010

Drug/Important Bio-Agent (IBA)

1Aurora KinasesIBA
01/2010
1MSC1992371AIBA
01/2010
1OxindolesIBA
03/2006
1Semaxinib (SU5416)IBA
03/2006

Therapy/Procedure

1Oral Administration
01/2010